Supplementary Materials_JAAD-D-24-02448
Published: 23 December 2024| Version 1 | DOI: 10.17632/fkvh7zp42t.1
Contributor:
Tai-Li ChenDescription
No Difference in Risk of Major Adverse Cardiovascular Events and Venous Thromboembolic Events Between Patients With Psoriasis or Psoriatic Arthritis on Tumor Necrosis Factor Inhibitors, Interleukin-17 Inhibitors, Interleukin-12/23 Inhibitors and Interleukin-23 Inhibitors: An Emulated Target Trial Analysis
Files
Institutions
Taipei Veterans General Hospital
Categories
Dermatology, Epidemiology of Psoriasis